The estimated Net Worth of Frederick Preiss is at least $2.18 Million dollars as of 14 June 2011. Frederick Preiss owns over 39,419 units of Atricure Inc stock worth over $1,705,971 and over the last 19 years Frederick sold ATRC stock worth over $472,600.
Frederick has made over 3 trades of the Atricure Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently Frederick exercised 39,419 units of ATRC stock worth $404,833 on 14 June 2011.
The largest trade Frederick's ever made was exercising 39,419 units of Atricure Inc stock on 14 June 2011 worth over $404,833. On average, Frederick trades about 5,014 units every 48 days since 2005. As of 14 June 2011 Frederick still owns at least 63,419 units of Atricure Inc stock.
You can see the complete history of Frederick Preiss stock trades at the bottom of the page.
Frederick's mailing address filed with the SEC is 6033 SCHUMACHER PARK DRIVE, , WEST CHESTER, OH, 45069.
Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie... und Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.
atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
Atricure Inc executives and other stock owners filed with the SEC include: